0 CHECKOUT

PRODUCT FILTERS

REGION

123
34
26
25
20

COUNTRY

17
16
16
15
15

CATEGORIES

  • 161
  • 81
  • 70
  • 54
  • 51
  • 51
  • 50
  • 34
  • 29
  • 25
  • 21
  • 20
  • 18
  • 18
  • 18
  • 18
  • 17
  • 16
  • 15
  • 15
  • 14
  • 13
  • 11
  • 11
  • 10
  • 9
  • 8
  • 8
  • 8
  • 8
  • 7
  • 7
  • 7
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

110
166
190
878

PUBLISHED

12
132
493
878

PRODUCT TYPE

715
87
68
6
1
1

Search for: "Cell Therapeutics Inc.-Therapeutic Competitors"

World Anti-Inflammatory Therapeutics Market - Opportunities and Forecasts, 2014 - 2020

Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks...

Published:  September 2015
Price:  From

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

Global Market Watch: Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017,...

Published:  April 2015
Price:  From

Sickle Cell Disease - Pipeline Review, H2 2015

Sickle Cell Disease - Pipeline Review, H2 2015 Summary The report ‘Sickle Cell Disease - Pipeline Review, H2 2015’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Sickle Cell Disease - Pipeline Review, H1 2015

Sickle Cell Disease - Pipeline Review, H1 2015 Summary This, ‘Sickle Cell Disease - Pipeline Review, H1 2015’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This report...

Published:  May 2015
Price:  From

Cesca Therapeutics Inc. (KOOL) - Product Pipeline Analysis, 2015 Update

Summary Cesca Therapeutics Inc. (Cesca) formerly ThermoGenesis Corp. is a medical equipment company. It researches, develops, and commercializes cell based therapeutics for application in regenerative...

Published:  October 2015
Price:  From

Renal Cell Carcinoma - Pipeline Review, H1 2015

Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary This, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This report...

Published:  June 2015
Price:  From

Renal Cell Carcinoma - Pipeline Review, H2 2015

Renal Cell Carcinoma - Pipeline Review, H2 2015 Summary The report ‘Renal Cell Carcinoma - Pipeline Review, H2 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This...

Published:  December 2015
Price:  From

Cell Therapeutics Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Cell Therapeutics Inc. Company Profile” is a comprehensive report on Cell Therapeutics Inc.. The report provides complete information on the operations, organization structure and financial information...

Published:  October 2014
Price:  From

Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

Non-Small Cell Lung Cancer - Pipeline Review, H1 2015 Summary the, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic...

Published:  June 2015
Price:  From

Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16 6 billion in 2012 to a projected value of $21 6 billion in 2019 This growth...

Published:  October 2013
Price:  From

Siamab Therapeutics, Inc. - Product Pipeline Analysis, 2015 Update

Summary Siamab Therapeutics, Inc. (Siamab Therapeutics) is a biopharmaceutical company. The company offers research and development of therapies targeting cancer cells expressing abnormal carbohydrates,...

Published:  December 2015
Price:  From

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

Published:  February 2015
Price:  From

Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma

“Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma” provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where...

Published:  February 2010
Price:  From

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  June 2015
Price:  From

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Transitional Cell Carcinoma (Urothelial Cell Carcinoma), complete with comparative analysis at various stages, therapeutics...

Published:  June 2015
Price:  From

Mantle Cell Lymphoma - Pipeline Review, H1 2015

Mantle Cell Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This report...

Published:  January 2015
Price:  From

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2015

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2015 Summary The report ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Kidney Cancer (Renal Cell...

Published:  December 2015
Price:  From

Ocata Therapeutics, Inc. (OCAT) - Financial and Strategic SWOT Analysis Review

Ocata Therapeutics, Inc. (OCAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  May 2015
Price:  From

World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 - 2020

Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks...

Published:  June 2015
Price:  From

Mantle Cell Lymphoma - Pipeline Review, H2 2015

Mantle Cell Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This...

Published:  October 2015
Price:  From
Loading Indicator

Our Clients

  • Deutsche Lufthansa AG
  • Cathay Pacific Airways Limited
  • Emirates Airline
  • Singapore Airlines
  • Korean Air
  • Air New Zealand